Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody

Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody

US Patent 10995150 · Granted May 4, 2021

Estimated economic value: $206,243,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhib2025
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof2025
FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof wi2024
ANGPTL8 assay and uses thereof2024
Non-human animals comprising a humanized ASGR1 locus2023
Anti-MSR1 antibodies and methods of use thereof2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Non-human animals having an engineered ANGPTL8 gene2020
Methods for treating patients with heterozygous familial hypercholesterolemia (h2020
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK92019
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK92019